Do analysts prefer CUPR or NRSN?

NeuroSense Therapeutics has a consensus price target of $8.50, indicating a potential upside of 1,114.29%. Given NeuroSense Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe NeuroSense Therapeutics is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NeuroSense Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60

Which has preferable earnings and valuation, CUPR or NRSN?

Cuprina Holdings (Cayman) has higher revenue and earnings than NeuroSense Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 694.63 -$3.63M N/A N/A NeuroSense Therapeutics N/A N/A -$11.12M -$0.54 N/A

Is CUPR or NRSN more profitable?

Company Net Margins Return on Equity Return on Assets Cuprina Holdings (Cayman) N/A N/A N/A NeuroSense Therapeutics N/A N/A N/A

Does the media prefer CUPR or NRSN?

In the previous week, Cuprina Holdings (Cayman) had 13 more articles in the media than NeuroSense Therapeutics. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 3 mentions for NeuroSense Therapeutics. NeuroSense Therapeutics' average media sentiment score of 0.63 beat Cuprina Holdings (Cayman)'s score of 0.58 indicating that NeuroSense Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cuprina Holdings (Cayman) 0 Very Positive mention(s) 0 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroSense Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate AYTU or CUPR?

Aytu BioPharma currently has a consensus price target of $9.83, indicating a potential upside of 351.07%. Given Aytu BioPharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Aytu BioPharma is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aytu BioPharma 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, AYTU or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Aytu BioPharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aytu BioPharma $66.38M 0.35 -$13.56M -$4.58 N/A Cuprina Holdings (Cayman) $40K 694.63 -$3.63M N/A N/A

Does the media favor AYTU or CUPR?

In the previous week, Cuprina Holdings (Cayman) had 6 more articles in the media than Aytu BioPharma. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 10 mentions for Aytu BioPharma. Cuprina Holdings (Cayman)'s average media sentiment score of 0.58 beat Aytu BioPharma's score of -0.16 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aytu BioPharma 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cuprina Holdings (Cayman) 0 Very Positive mention(s) 0 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer DYAI or CUPR?

Dyadic International currently has a consensus price target of $3.00, suggesting a potential upside of 294.74%. Given Dyadic International's stronger consensus rating and higher probable upside, equities analysts plainly believe Dyadic International is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, DYAI or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Dyadic International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dyadic International $3.09M 8.96 -$7.36M -$0.23 N/A Cuprina Holdings (Cayman) $40K 694.63 -$3.63M N/A N/A

Does the media favor DYAI or CUPR?

In the previous week, Cuprina Holdings (Cayman) had 13 more articles in the media than Dyadic International. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 3 mentions for Dyadic International. Cuprina Holdings (Cayman)'s average media sentiment score of 0.58 beat Dyadic International's score of 0.44 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cuprina Holdings (Cayman) 0 Very Positive mention(s) 0 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CUPR or SCYX?

SCYNEXIS has a consensus price target of $24.00, indicating a potential upside of 462.19%. Given SCYNEXIS's stronger consensus rating and higher probable upside, analysts clearly believe SCYNEXIS is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SCYNEXIS 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, CUPR or SCYX?

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than SCYNEXIS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cuprina Holdings (Cayman) $40K 694.63 -$3.63M N/A N/A SCYNEXIS $20.60M 1.16 -$8.61M -$3.84 N/A

Do analysts rate LGVN or CUPR?

Longeveron presently has a consensus target price of $5.50, indicating a potential upside of 591.82%. Given Longeveron's stronger consensus rating and higher possible upside, equities analysts clearly believe Longeveron is more favorable than Cuprina Holdings (Cayman). Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Longeveron 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, LGVN or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Longeveron. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Longeveron $1.20M 20.64 -$22.70M -$1.13 N/A Cuprina Holdings (Cayman) $40K 694.63 -$3.63M N/A N/A

Does the media favor LGVN or CUPR?

In the previous week, Cuprina Holdings (Cayman) had 10 more articles in the media than Longeveron. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 6 mentions for Longeveron. Longeveron's average media sentiment score of 0.85 beat Cuprina Holdings (Cayman)'s score of 0.58 indicating that Longeveron is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Longeveron 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cuprina Holdings (Cayman) 0 Very Positive mention(s) 0 Positive mention(s) 14 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Trading of Cuprina Holdings (Cayman) was halted at 11:50 AM EST due to "LULD Pause".

Cuprina Holdings (Cayman) (CUPR) Competitors

$10.60 +6.64 (+167.13%)

As of 12:02 PM Eastern

Compare

CUPR vs. NRSN, AYTU, DYAI, SCYX, and LGVN

Should you buy Cuprina Holdings (Cayman) stock or one of its competitors? MarketBeat compares Cuprina Holdings (Cayman) with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cuprina Holdings (Cayman) include NeuroSense Therapeutics (NRSN), Aytu BioPharma (AYTU), Dyadic International (DYAI), SCYNEXIS (SCYX), and Longeveron (LGVN). These companies are all part of the "pharmaceutical products" industry.

How does Cuprina Holdings (Cayman) compare to NeuroSense Therapeutics?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and NeuroSense Therapeutics (NASDAQ:NRSN) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, Cuprina Holdings (Cayman) had 13 more articles in the media than NeuroSense Therapeutics. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 3 mentions for NeuroSense Therapeutics. NeuroSense Therapeutics' average media sentiment score of 0.63 beat Cuprina Holdings (Cayman)'s score of 0.58 indicating that NeuroSense Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cuprina Holdings (Cayman)	0 Very Positive mention(s)	0 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroSense Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroSense Therapeutics has a consensus price target of $8.50, indicating a potential upside of 1,114.29%. Given NeuroSense Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe NeuroSense Therapeutics is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NeuroSense Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Cuprina Holdings (Cayman) has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market. Comparatively, NeuroSense Therapeutics has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

Cuprina Holdings (Cayman) has higher revenue and earnings than NeuroSense Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	694.63	-$3.63M	N/A	N/A
NeuroSense Therapeutics	N/A	N/A	-$11.12M	-$0.54	N/A

1.0% of NeuroSense Therapeutics shares are owned by institutional investors. 27.4% of NeuroSense Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
NeuroSense Therapeutics	N/A	N/A	N/A

Summary

NeuroSense Therapeutics beats Cuprina Holdings (Cayman) on 7 of the 11 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Aytu BioPharma?

Aytu BioPharma (NASDAQ:AYTU) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Aytu BioPharma currently has a consensus price target of $9.83, indicating a potential upside of 351.07%. Given Aytu BioPharma's stronger consensus rating and higher probable upside, equities analysts plainly believe Aytu BioPharma is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aytu BioPharma	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Cuprina Holdings (Cayman) had 6 more articles in the media than Aytu BioPharma. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 10 mentions for Aytu BioPharma. Cuprina Holdings (Cayman)'s average media sentiment score of 0.58 beat Aytu BioPharma's score of -0.16 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aytu BioPharma	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cuprina Holdings (Cayman)	0 Very Positive mention(s)	0 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

33.5% of Aytu BioPharma shares are held by institutional investors. 4.9% of Aytu BioPharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Aytu BioPharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aytu BioPharma	$66.38M	0.35	-$13.56M	-$4.58	N/A
Cuprina Holdings (Cayman)	$40K	694.63	-$3.63M	N/A	N/A

Aytu BioPharma has a beta of 0.25, indicating that its share price is 75% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of 2.3, indicating that its share price is 130% more volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Aytu BioPharma's net margin of -60.17%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Aytu BioPharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aytu BioPharma	-60.17%	-69.93%	-13.25%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Summary

Cuprina Holdings (Cayman) beats Aytu BioPharma on 8 of the 14 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Dyadic International?

Dyadic International (NASDAQ:DYAI) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Dyadic International's net margin of -192.40%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Dyadic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dyadic International	-192.40%	-1,005.45%	-77.64%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

28.0% of Dyadic International shares are held by institutional investors. 20.9% of Dyadic International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Dyadic International has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market.

In the previous week, Cuprina Holdings (Cayman) had 13 more articles in the media than Dyadic International. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 3 mentions for Dyadic International. Cuprina Holdings (Cayman)'s average media sentiment score of 0.58 beat Dyadic International's score of 0.44 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dyadic International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cuprina Holdings (Cayman)	0 Very Positive mention(s)	0 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Dyadic International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dyadic International	$3.09M	8.96	-$7.36M	-$0.23	N/A
Cuprina Holdings (Cayman)	$40K	694.63	-$3.63M	N/A	N/A

Dyadic International currently has a consensus price target of $3.00, suggesting a potential upside of 294.74%. Given Dyadic International's stronger consensus rating and higher probable upside, equities analysts plainly believe Dyadic International is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dyadic International	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Cuprina Holdings (Cayman) beats Dyadic International on 8 of the 14 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to SCYNEXIS?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and SCYNEXIS (NASDAQ:SCYX) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Cuprina Holdings (Cayman) has higher earnings, but lower revenue than SCYNEXIS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cuprina Holdings (Cayman)	$40K	694.63	-$3.63M	N/A	N/A
SCYNEXIS	$20.60M	1.16	-$8.61M	-$3.84	N/A

54.4% of SCYNEXIS shares are held by institutional investors. 4.1% of SCYNEXIS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to SCYNEXIS's net margin of -41.79%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat SCYNEXIS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cuprina Holdings (Cayman)	N/A	N/A	N/A
SCYNEXIS	-41.79%	-57.16%	-39.48%

In the previous week, Cuprina Holdings (Cayman) had 15 more articles in the media than SCYNEXIS. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 1 mentions for SCYNEXIS. SCYNEXIS's average media sentiment score of 1.87 beat Cuprina Holdings (Cayman)'s score of 0.58 indicating that SCYNEXIS is being referred to more favorably in the news media.

Company	Overall Sentiment
Cuprina Holdings (Cayman)	Positive
SCYNEXIS	Very Positive

Cuprina Holdings (Cayman) has a beta of 2.3, meaning that its stock price is 130% more volatile than the broader market. Comparatively, SCYNEXIS has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

SCYNEXIS has a consensus price target of $24.00, indicating a potential upside of 462.19%. Given SCYNEXIS's stronger consensus rating and higher probable upside, analysts clearly believe SCYNEXIS is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SCYNEXIS	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Cuprina Holdings (Cayman) and SCYNEXIS tied by winning 7 of the 14 factors compared between the two stocks.

How does Cuprina Holdings (Cayman) compare to Longeveron?

Longeveron (NASDAQ:LGVN) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Longeveron.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Longeveron	$1.20M	20.64	-$22.70M	-$1.13	N/A
Cuprina Holdings (Cayman)	$40K	694.63	-$3.63M	N/A	N/A

Longeveron has a beta of -0.35, suggesting that its share price is 135% less volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Longeveron's net margin of -1,844.49%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Longeveron's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Longeveron	-1,844.49%	-202.41%	-140.67%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

In the previous week, Cuprina Holdings (Cayman) had 10 more articles in the media than Longeveron. MarketBeat recorded 16 mentions for Cuprina Holdings (Cayman) and 6 mentions for Longeveron. Longeveron's average media sentiment score of 0.85 beat Cuprina Holdings (Cayman)'s score of 0.58 indicating that Longeveron is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Longeveron	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cuprina Holdings (Cayman)	0 Very Positive mention(s)	0 Positive mention(s)	14 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Longeveron presently has a consensus target price of $5.50, indicating a potential upside of 591.82%. Given Longeveron's stronger consensus rating and higher possible upside, equities analysts clearly believe Longeveron is more favorable than Cuprina Holdings (Cayman).

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Longeveron	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

10.0% of Longeveron shares are owned by institutional investors. 7.4% of Longeveron shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Longeveron and Cuprina Holdings (Cayman) tied by winning 7 of the 14 factors compared between the two stocks.

Get Cuprina Holdings (Cayman) News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CUPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CUPR vs. The Competition

Export

Metric	Cuprina Holdings (Cayman)	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$28.60M	$970.92M	$4.35B	$12.37B
Dividend Yield	N/A	4.84%	10.25%	5.66%
P/E Ratio	N/A	1.47	22.31	24.71
Price / Sales	694.63	127.72	130.19	165.59
Price / Cash	N/A	20.06	40.19	37.92
Price / Book	7.07	8.02	26.47	6.85
Net Income	-$3.63M	-$4.88M	$116.61M	$337.45M
7 Day Performance	324.20%	4.75%	2.36%	2.70%
1 Month Performance	380.30%	4.52%	2.38%	4.60%
1 Year Performance	N/A	47.58%	15.30%	32.81%

Cuprina Holdings (Cayman) Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CUPR Cuprina Holdings (Cayman)	0.9545 of 5 stars	$10.61 +167.1%	N/A	N/A	$28.60M	$40K	N/A	14	Gap Up Trading Halted High Trading Volume
NRSN NeuroSense Therapeutics	3.2324 of 5 stars	$0.73 -3.8%	$8.50 +1,062.3%	-69.1%	$24.74M	N/A	N/A	10	Upcoming Earnings Gap Up
AYTU Aytu BioPharma	3.0025 of 5 stars	$2.24 -2.6%	$9.33 +316.7%	+10.3%	$24.69M	$56.60M	N/A	160	News Coverage Analyst Revision Gap Up
DYAI Dyadic International	2.3309 of 5 stars	$0.73 +8.1%	$3.00 +311.0%	-27.4%	$24.61M	$3.09M	N/A	7	News Coverage Gap Up
SCYX SCYNEXIS	2.3363 of 5 stars	$4.15 -4.8%	$24.00 +478.3%	-34.5%	$24.34M	$20.60M	N/A	60	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CUPR) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cuprina Holdings (Cayman) (CUPR) Competitors

CUPR vs. NRSN, AYTU, DYAI, SCYX, and LGVN

How does Cuprina Holdings (Cayman) compare to NeuroSense Therapeutics?

Summary

How does Cuprina Holdings (Cayman) compare to Aytu BioPharma?

Summary

How does Cuprina Holdings (Cayman) compare to Dyadic International?

Summary

How does Cuprina Holdings (Cayman) compare to SCYNEXIS?

Summary

How does Cuprina Holdings (Cayman) compare to Longeveron?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CUPR vs. The Competition

Cuprina Holdings (Cayman) Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cuprina Holdings (Cayman) (CUPR) Competitors

CUPR vs. NRSN, AYTU, DYAI, SCYX, and LGVN

How does Cuprina Holdings (Cayman) compare to NeuroSense Therapeutics?

Does the media prefer CUPR or NRSN?

Do analysts prefer CUPR or NRSN?

Which has more risk & volatility, CUPR or NRSN?

Which has preferable earnings and valuation, CUPR or NRSN?

Do institutionals and insiders believe in CUPR or NRSN?

Is CUPR or NRSN more profitable?

Summary

How does Cuprina Holdings (Cayman) compare to Aytu BioPharma?

Do analysts rate AYTU or CUPR?

Does the media favor AYTU or CUPR?

Do insiders & institutionals believe in AYTU or CUPR?

Which has higher earnings and valuation, AYTU or CUPR?

Which has more volatility & risk, AYTU or CUPR?

Is AYTU or CUPR more profitable?

Summary

How does Cuprina Holdings (Cayman) compare to Dyadic International?

Is DYAI or CUPR more profitable?

Do institutionals & insiders have more ownership in DYAI or CUPR?

Which has more volatility & risk, DYAI or CUPR?

Does the media favor DYAI or CUPR?

Which has preferable earnings & valuation, DYAI or CUPR?

Do analysts prefer DYAI or CUPR?

Summary

How does Cuprina Holdings (Cayman) compare to SCYNEXIS?

Which has better earnings & valuation, CUPR or SCYX?

Do institutionals & insiders believe in CUPR or SCYX?

Is CUPR or SCYX more profitable?

Does the media refer more to CUPR or SCYX?

Which has more volatility & risk, CUPR or SCYX?

Do analysts rate CUPR or SCYX?

Summary

How does Cuprina Holdings (Cayman) compare to Longeveron?

Which has better earnings & valuation, LGVN or CUPR?

Which has more risk and volatility, LGVN or CUPR?

Is LGVN or CUPR more profitable?

Does the media favor LGVN or CUPR?

Do analysts rate LGVN or CUPR?

Do institutionals and insiders hold more shares of LGVN or CUPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CUPR vs. The Competition

Cuprina Holdings (Cayman) Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools